Cargando…
B Cell Modulation Strategies in Autoimmune Diseases: New Concepts
B cells are major effector cells in autoimmunity through antibody production, T cell help and pro-inflammatory cytokine production. Major advances have been made in human B cell biology knowledge using rituximab and type II new anti-CD20 antibodies, anti-CD19 antibodies, anti-CD22 antibodies, autoan...
Autores principales: | Musette, Philippe, Bouaziz, Jean David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908887/ https://www.ncbi.nlm.nih.gov/pubmed/29706952 http://dx.doi.org/10.3389/fimmu.2018.00622 |
Ejemplares similares
-
Editorial: Strategies for Modulating T Cell Responses in Autoimmunity and Infection
por: Pascutti, María Fernanda, et al.
Publicado: (2020) -
Abnormal B cell glycosylation in autoimmunity: A new potential treatment strategy
por: Morel, Marie, et al.
Publicado: (2022) -
Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases
por: Lee, Jae-Ung, et al.
Publicado: (2018) -
Editorial: Understanding the concept of pre-clinical autoimmunity
por: Olsen, Nancy J., et al.
Publicado: (2022) -
Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases
por: Dekkers, Gillian, et al.
Publicado: (2018)